Related Experiment Video

Updated: Feb 6, 2026

Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells
06:33

Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells

Published on: February 2, 2024

2.6K

SIRT5 regulates pancreatic β-cell proliferation and insulin secretion in type 2 diabetes

Yongmei Ma1, Xiaoqiang Fei1

  • 1Department of Endocrinology, Taizhou People's Hospital, Taizhou, Jiangsu 225300, P.R. China.

Experimental and Therapeutic Medicine
|August 18, 2018
PubMed

Insights

Sirtuin 5 (SIRT5) is elevated in type 2 diabetes (T2D), suppressing insulin secretion and beta-cell proliferation. Lowering SIRT5 may improve insulin secretion, offering a new therapeutic target for T2D.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Metabolic Diseases

Background:

  • Type 2 diabetes (T2D) is characterized by impaired insulin secretion and insulin resistance.
  • The precise mechanisms behind insulin secretion failure in T2D remain unclear.
  • Understanding these mechanisms is crucial for developing effective T2D treatments.

Purpose of the Study:

  • To investigate the role of sirtuin 5 (SIRT5) in the pathogenesis of type 2 diabetes.
  • To explore the relationship between SIRT5 expression and pancreatic beta-cell function.
  • To identify SIRT5 as a potential therapeutic target for T2D.

Main Methods:

  • Analysis of SIRT5 expression in T2D patients and pancreatic beta-cell lines.
  • Correlation analysis of SIRT5 expression with age, blood glucose, and PDX1 levels.
  • In vitro assays (colony formation, CCK-8) to assess SIRT5's effect on beta-cell proliferation.
  • Investigation of SIRT5's impact on insulin secretion and PDX1 expression.
  • Chromatin immunoprecipitation (ChIP) assay to determine SIRT5's regulatory mechanism on PDX1 transcription.

Main Results:

  • SIRT5 was found to be upregulated in T2D patients and beta-cell lines.
  • Elevated SIRT5 expression correlated positively with age and blood glucose, and negatively with PDX1.
  • SIRT5 suppressed pancreatic beta-cell proliferation in vitro.
  • Downregulation of SIRT5 enhanced insulin secretion.
  • SIRT5 regulated PDX1 expression, potentially via H4K16 deacetylation.

Conclusions:

  • SIRT5 plays a significant role in the pathogenesis of type 2 diabetes.
  • SIRT5 negatively impacts pancreatic beta-cell proliferation and insulin secretion.
  • SIRT5's regulation of PDX1 suggests a novel molecular mechanism in T2D.
  • SIRT5 represents a potential novel therapeutic target for T2D treatment.
Keywords:
insulin secretionpancreatic and duodenal homeobox 1proliferationsirtuin 5type 2 diabetes

More Related Videos

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets10:09

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

10.1K
Coculture Analysis of Extracellular Protein Interactions Affecting Insulin Secretion by Pancreatic Beta Cells05:51

Coculture Analysis of Extracellular Protein Interactions Affecting Insulin Secretion by Pancreatic Beta Cells

Published on: June 15, 2013

13.4K

Related Concept Videos

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
2.6K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
Pancreatic Juice and Secretion01:26

Pancreatic Juice and Secretion

Pancreatic juice is a clear fluid produced by the pancreas, containing water, salts, sodium bicarbonate, and enzymes vital for digestion in the small intestine. It helps break down large molecules, facilitating nutrient absorption.
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
3.1K
Regulation of Hormone Secretion01:19

Regulation of Hormone Secretion

Regulation of hormone secretion is a finely tuned orchestration driven by various types of stimuli, encompassing neural, humoral, and hormonal signals. Environmental cues instigate neural stimuli, where action potentials traverse nerve fibers to reach their designated targets. An illustrative scenario is the body's response to stress, wherein the sympathetic nervous system releases epinephrine from the adrenal glands, inducing the well-known 'fight or flight' reaction.
Humoral...
6.9K
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
758
Exocrine Glands: Types of Secretions01:13

Exocrine Glands: Types of Secretions

Exocrine glands produce and release a variety of glandular products. Exocrine glands can be classified into serous, mucous, or mixed types based on their secretory products.
Serous glands produce watery secretions rich in digestive enzymes and proteins. The constituent cells of the serous gland have centrally located nuclei and eosinophilic secretory granules in the cytoplasm. The parotid gland is an example of a serous gland. It secretes saliva, which contains enzymes, such as lipases and...
3.9K